Xolair 300 mg/2mL
omalizumab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
Xolair is a injection, solution containing omalizumab at 300 mg/2mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Xolair
- Generic Name
- omalizumab
- NDC Code (Product)
50242-227- Manufacturer
- Genentech, Inc.
- Strength
- 300 mg/2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103976
- Drug Class
- Anti-IgE [EPC]
- Marketing Start
- 08/18/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Xolair used for?
Xolair contains omalizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Xolair a controlled substance?
Xolair is not classified as a controlled substance by the DEA.
What is the generic name for Xolair?
The generic name for Xolair is omalizumab. There are 3 other brand versions of omalizumab.
What is the NDC code for Xolair 300 mg/2mL?
The NDC (National Drug Code) for Xolair 300 mg/2mL is 50242-227, listed by Genentech, Inc..